These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20530317)

  • 1. A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder.
    Rosenberg RP; Bogan RK; Tiller JM; Yang R; Youakim JM; Earl CQ; Roth T
    Mayo Clin Proc; 2010 Jul; 85(7):630-8. PubMed ID: 20530317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.
    Czeisler CA; Walsh JK; Wesnes KA; Arora S; Roth T
    Mayo Clin Proc; 2009 Nov; 84(11):958-72. PubMed ID: 19880686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension.
    Menn SJ; Yang R; Lankford A
    J Clin Sleep Med; 2014 Nov; 10(11):1181-91. PubMed ID: 25325609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Armodafinil.
    Garnock-Jones KP; Dhillon S; Scott LJ
    CNS Drugs; 2009 Sep; 23(9):793-803. PubMed ID: 19689169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
    Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
    Harsh JR; Hayduk R; Rosenberg R; Wesnes KA; Walsh JK; Arora S; Niebler GE; Roth T
    Curr Med Res Opin; 2006 Apr; 22(4):761-74. PubMed ID: 16684437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships.
    Darwish M; Bond M; Ezzet F
    J Clin Pharmacol; 2012 Sep; 52(9):1328-42. PubMed ID: 22039290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T; Rippon GA; Arora S
    Sleep Breath; 2008 Mar; 12(1):53-62. PubMed ID: 17874255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.
    Black JE; Hull SG; Tiller J; Yang R; Harsh JR
    J Clin Sleep Med; 2010 Oct; 6(5):458-66. PubMed ID: 20957846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic exposure to armodafinil and its tolerability in healthy elderly versus young men: an open-label, multiple-dose, parallel-group study.
    Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P
    Drugs Aging; 2011 Feb; 28(2):139-50. PubMed ID: 21275439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss.
    Dinges DF; Arora S; Darwish M; Niebler GE
    Curr Med Res Opin; 2006 Jan; 22(1):159-67. PubMed ID: 16393442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period.
    Schwartz JR; Khan A; McCall WV; Weintraub J; Tiller J
    J Clin Sleep Med; 2010 Oct; 6(5):450-7. PubMed ID: 20957845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of armodafinil on simulated driving and alertness in shift work disorder.
    Drake C; Gumenyuk V; Roth T; Howard R
    Sleep; 2014 Dec; 37(12):1987-94. PubMed ID: 25325498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.
    Lower EE; Malhotra A; Surdulescu V; Baughman RP
    J Pain Symptom Manage; 2013 Feb; 45(2):159-69. PubMed ID: 22917711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
    Kane JM; D'Souza DC; Patkar AA; Youakim JM; Tiller JM; Yang R; Keefe RS
    J Clin Psychiatry; 2010 Nov; 71(11):1475-81. PubMed ID: 20816042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study.
    Greve DN; Duntley SP; Larson-Prior L; Krystal AD; Diaz MT; Drummond SP; Thein SG; Kushida CA; Yang R; Thomas RJ
    J Clin Sleep Med; 2014 Feb; 10(2):143-53. PubMed ID: 24532997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.